Omnicell (OMCL) Competitors

Omnicell (NASDAQ:OMCL) and HealthStream (NASDAQ:HSTM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations, community ranking and risk.

Is OMCL or HSTM more profitable?

HealthStream has a net margin of 6.84% compared to Omnicell's net margin of 1.13%. HealthStream's return on equity of 5.67% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	1.13%	3.82%	2.07%
HealthStream	6.84%	5.67%	3.91%

Do institutionals & insiders hold more shares of OMCL or HSTM?

97.7% of Omnicell shares are held by institutional investors. Comparatively, 69.6% of HealthStream shares are held by institutional investors. 2.5% of Omnicell shares are held by company insiders. Comparatively, 20.6% of HealthStream shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community favor OMCL or HSTM?

Omnicell received 43 more outperform votes than HealthStream when rated by MarketBeat users. Likewise, 66.75% of users gave Omnicell an outperform vote while only 66.43% of users gave HealthStream an outperform vote.

Company	Underperform	Outperform
Omnicell	Outperform Votes 506 66.75%	Underperform Votes 252 33.25%
HealthStream	Outperform Votes 463 66.43%	Underperform Votes 234 33.57%

Do analysts rate OMCL or HSTM?

Omnicell presently has a consensus price target of $46.50, suggesting a potential upside of 66.25%. HealthStream has a consensus price target of $31.50, suggesting a potential upside of 10.44%. Given Omnicell's higher possible upside, analysts plainly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
HealthStream	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80

Which has more volatility and risk, OMCL or HSTM?

Omnicell has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, HealthStream has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500.

Which has preferable earnings & valuation, OMCL or HSTM?

HealthStream has lower revenue, but higher earnings than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.14B	1.15	$12.53M	$0.46	60.80
HealthStream	$292.37M	2.98	$15.21M	$0.63	45.27

Does the media prefer OMCL or HSTM?

In the previous week, HealthStream had 3 more articles in the media than Omnicell. MarketBeat recorded 14 mentions for HealthStream and 11 mentions for Omnicell. Omnicell's average media sentiment score of 1.20 beat HealthStream's score of 0.71 indicating that Omnicell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthStream	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

HealthStream beats Omnicell on 10 of the 19 factors compared between the two stocks.